Results 71 to 80 of about 10,746,438 (360)

Antiviral response and HIV-1 inhibition in sickle cell disease

open access: yesiScience
Summary: Sickle cell disease (SCD) is characterized by hemolysis, vaso-occlusion, and ischemia. HIV-1 infection was previously shown to be suppressed in SCD PBMCs.
Namita Kumari   +10 more
doaj   +1 more source

Cerebral hemodynamics and oxygenation in adult patients with sickle cell disease after stem cell transplantation [PDF]

open access: hybrid, 2023
Liza Afzali‐Hashemi   +7 more
openalex   +1 more source

Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment

open access: yesInternational Journal of Neonatal Screening, 2019
Sickle cell disease (SCD) is a monogenetic disorder due to a single base-pair point mutation in the β-globin gene resulting in the substitution of the amino acid valine for glutamic acid in the β-globin chain.
B. Inusa   +6 more
semanticscholar   +1 more source

Differential sensitivity of midline development to mitosis during and after primitive streak extension

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Background Midline establishment is a fundamental process during early embryogenesis for Bilaterians. Midline morphogenesis in non‐amniotes can occur without mitosis, through Planar Cell Polarity (PCP) signaling. By contrast, amniotes utilize both cellular processes for developing the early midline landmark, the primitive streak (PS).
Zhiling Zhao, Rieko Asai, Takashi Mikawa
wiley   +1 more source

Búsqueda de hemoglobinas anormales en los recién nacidos en las grandes alturas.

open access: yesRevista Médica Herediana, 1997
Se hizo un muestreo para detectar hemoglobinas anormales en Recién Nacidos (RN) de tres ciudades andinas situadas en el Perú: Cerro de Pasco, Huancayo y Puno. Estas ciudades estan situadas en altitudes que fluctúan entre los 3,500 a 4,400 m.
Dante ROA   +4 more
doaj  

Sickle Cell Safari [PDF]

open access: yesBlood, 1973
Abstract A narrative concerning mass screening of a large population at risk for sickle hemolobin, glucose-6-phosphate dehydrogenase deficiency, anemia, and lead poisoning is presented. At the time of writing, more than one-tenth of a black community totaling over 104,000 individuals have been tested.
openaire   +2 more sources

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

open access: yesEnvironmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons   +17 more
wiley   +1 more source

Nutritional Potential, Phytochemical Content, In Vivo Antioxidant, and Antanemic Potential of Musa paradisiaca Flower

open access: yesFood Chemistry International, EarlyView.
After collecting Musa paradisiaca leaves, some were dried and others were used to produce aqueous extracts. The extracts and powders were characterized and then administered to rats made anaemic by PHZ. After 14 days of administration of the two samples, the rats were euthanized and it was observed that after 9 days of treatment, the aqueous extract ...
Josée Rebeca Nombo   +8 more
wiley   +1 more source

Relationships Between Markers of Iron Status and Hematological Parameters in Patients With Sickle Cell Disease

open access: yesAdvances in Hematology
Based on the relationship between the intracellular concentration of sickle hemoglobin S (HbS) and the delay that occurs prior to the onset of sickling following deoxygenation, targeting the intracellular HbS concentration is a recognized therapeutic ...
Nermi L. Parrow   +4 more
doaj   +1 more source

Newborn Sickle Cell and Thalassaemia Screening Programme: Automating and Enhancing the System to Evaluate the Screening Programme

open access: yesInternational Journal of Neonatal Screening, 2019
Good information is needed to demonstrate that a screening programme is meeting its objectives, to measure performance against standards and to ensure that action is taken if standards are not met.
Catherine Coppinger, Robyn O’Loughlin
doaj   +1 more source

Home - About - Disclaimer - Privacy